We are pleased to share with you the exciting news that Medasense has received AMAR approval to sell our pain (Nociception) monitoring system in Israel!
Israeli anesthesiologists are now able to join their European colleagues, who are
already using our technology , to optimize and personalize the intraoperative analgesic administration.
This is a significant milestone for Medasense. We are very proud to enter our home market, where our technology was developed!